Form 4 for MGX Metagenomi Therapeutics, Inc.
Accepted 2026-03-09 00:00:00 ET · period of report 2025-12-05 · accession 0001193125-26-098820 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-09 | 2025-12-05 | MGX | Irish Jian | CEO, Dir | G - Gift | $0.00 | -228.5K | 335.4K | -41% | $0 | |
| 2026-03-09 | 2026-03-05 | MGX | Irish Jian | CEO, Dir | S - Sale | $1.60 | -1,607 | 333.8K | -0.5% | -$2,571 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-05 | G | D | 228,462 | $0.00 | 335,377 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-05 | S | D | 1,607 | $1.60 | 333,770 | D | — | — |